Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox and occlusal splint for headache attributed to temporomandibular disorder
2018-001912-31Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in Headache attributed to temporomandibular disorder and temporomandibular disorder (TMD) (3 arms), sponsored by University Medical Centre Ljubljana. Started Nov 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Headache attributed to temporomandibular disordertemporomandibular disorder (TMD)
Beyond the preview
Go deeper on 2018-001912-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001912-31.